Literature DB >> 1422584

Rabbit isolated renal artery contractions by some tryptamine derivatives, including 2-methyl-5-HT, are mediated by a 5-HT1-like receptor.

S Tadipatri1, W Feniuk, P R Saxena.   

Abstract

1. Despite the fact that 5-hydroxytryptamine (5-HT)-induced contractions of the rabbit isolated renal artery are mediated by a receptor belonging to the heterogeneous 5-HT1-like category, we observed that the so-called selective 5-HT3 receptor agonist, 2-methyl-5-HT, caused a concentration-dependent contraction of this vessel. This study was therefore undertaken to analyze the effects of 2-methyl-5-HT in the renal artery segments, either quiescent or precontracted with U46619 (10(-7) M). alpha-Methyl-5-HT and 5-methoxytryptamine, which have high affinities for 5-HT2 and 5-HT4 receptors, respectively, were used for comparison. 2. In the precontracted vessel segments, the maximum contractile responses obtained with 2-methyl-5-HT, alpha-methyl-5-HT, 5-methoxytryptamine and 5-HT were similar to those in the quiescent segments. However the pD2 values were higher in the precontracted segments, making them about 4-100 fold more sensitive. 3. Neither MDL 72222 (10(-6) M) nor tropisetron (3 x 10(-6) M) suppressed renal artery contractions elicited by 5-HT, 2-methyl-5-HT, alpha-methyl-5-HT or 5-methoxytryptamine, thus ruling out the involvement of 5-HT3 as well as 5-HT4 receptors. 4. On the other hand, both methiothepin (10(-8) and 10(-7) M) and ketanserin (10(-7) and 10(-6) M) caused a rightward shift of agonist concentration-effect curves.The two antagonists had similar pA2 values against the different agonists tested on either quiescent or precontracted vessels, but ketanserin (apparent pA2: 6.6 to 7.0) was between 20-100 fold less potent than methiothepin (apparent pA2: 8.4 to 8.8).5. The results of this functional study permit us to conclude that the contractile effects of 2-methyl-5-HT as well as ct-methyl-5-HT and 5-methoxytryptamine on the rabbit isolated renal artery are mediated by a 5-HT1-like receptor. Since, in addition, the reported ligand binding affinity of 2-methyl-5-HT at 5-HT3 receptors is similar to both the ligand binding affinity and the functional pD2 at 5-HTI sites, this compound cannot be regarded as a selective 5-HT3 receptor agonist. Similarly, a-methyl-5-HT and 5-methoxytryptamine have only a limited selectivity for 5-HT2 and 5-HT4 receptors, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422584      PMCID: PMC1907858          DOI: 10.1111/j.1476-5381.1992.tb12745.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Contractile 5-HT1 receptors in human isolated pial arterioles: correlation with 5-HT1D binding sites.

Authors:  E Hamel; D Bouchard
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

Review 2.  Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments?

Authors:  P Leff; I G Dougall; D H Harper; I A Dainty
Journal:  Trends Pharmacol Sci       Date:  1990-02       Impact factor: 14.819

3.  Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.

Authors:  D Hoyer; H C Neijt
Journal:  Mol Pharmacol       Date:  1988-03       Impact factor: 4.436

4.  Receptors mediating the effects of 5-hydroxytryptamine on the tracheal vasculature and smooth muscle of sheep.

Authors:  S E Webber; R O Salonen; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

5.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

Authors:  B P Richardson; G Engel; P Donatsch; P A Stadler
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

6.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

7.  5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.

Authors:  P Schoeffter; D Hoyer
Journal:  J Pharmacol Exp Ther       Date:  1990-01       Impact factor: 4.030

8.  A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.

Authors:  A Dumuis; R Bouhelal; M Sebben; R Cory; J Bockaert
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

9.  A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists.

Authors:  W Feniuk; P P Humphrey; M J Perren; A D Watts
Journal:  Br J Pharmacol       Date:  1985-11       Impact factor: 8.739

10.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more
  4 in total

Review 1.  Role of the serotonergic system in alcohol dependence: from animal models to clinics.

Authors:  Youssef Sari; Verity R Johnson; Jason M Weedman
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

2.  5-HT1-like and 5-HT2A receptors mediate 5-hydroxytryptamine-induced contraction of rabbit isolated mesenteric artery.

Authors:  O Yildiz; M Tuncer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

3.  Mediation by 5-HT1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries.

Authors:  V Deckert; D Pruneau; J L Elghozi
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

4.  5-Hydroxytryptamine (5-HT) contracts the guinea-pig isolated iliac artery via 5-HT1-like and 5-HT2 receptors.

Authors:  H Pertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.